Stay updated on MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T14:34:36.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It does not change details about the study.
    Difference
    0.8%
    Check dated 2026-10-25T13:44:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:03:21.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-11T13:22:01.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 is added to the study's history while the previous revision tag v3.6.6 is removed, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-09-20T14:12:49.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous entry v3.6.5 was deleted. This represents an administrative update to the version history of the study record.
    Difference
    0.1%
    Check dated 2026-08-29T23:50:54.000Z thumbnail image

Stay in the know with updates to MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Pathway Inhibitors in Hematologic Malignancies Clinical Trial page.